Sleep disturbance has taken on new importance with the observation
that the drugs etanercept and infliximab reduce daytime sleepiness,
and patients indicate that sleep is an important issue. The researchers
evaluated 8,676 patients with rheumatoid arthritis (RA) and a comparison
group of 1,364 subjects with non-fibromyalgia, noninflammatory disorders
(NID) using questionnaires. Sleep disturbance is increased in RA, and
25% to 42% of sleep disturbance can be attributed to RA. SD is linked
to pain, mood, and disease activity. SD is slightly greater in women
and is less with increasing age. Wolfe F, Michaud K, Li T. Adapted from
J Rheumatol. 2006 Oct;33(10):1942-51. Epub 2006 Sep 1.
PMID 16960928
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
Credit: PubMed, developed by the National Center for Biotechnology Information
(NCBI) at the National
Library of Medicine (NLM).
|
